Sysmex (TSE:6869) Asset Impairment Charge : 円0 Mil (TTM As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

What is Sysmex Asset Impairment Charge?

Sysmex's Asset Impairment Charge for the three months ended in Dec. 2023 was 円0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 was 円0 Mil.

Sysmex Asset Impairment Charge Historical Data

The historical data trend for Sysmex's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sysmex Asset Impairment Charge Chart

Sysmex Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Asset Impairment Charge

Get a 7-Day Free Trial

Sysmex Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

Sysmex Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

Sysmex Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Sysmex's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Sysmex (TSE:6869) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sysmex Corp (TSE:6869) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

SSMXY:USA SSMXF:USA 0YX:Germany

Address

1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, JPN, 6510073

Website

http://www.sysmex.co.jp

Sysmex Corp manufactures and distributes in vitro diagnostic instruments, reagents, and software. The vast majority of the firm's revenue comes from selling tests for human bodily fluids to hospitals and commercial laboratories. Within this industry, the firm specializes in hematology reagents and instruments. Sysmex also sells in vitro diagnostics for applications like urinalysis and hemostasis and provides support and maintenance services for its systems. Over half of the firm's revenue is generated by sales of reagents and services, which are recurring sources of income. Sysmex primarily sells its products to customers in Japan, Europe, the Middle East, and Africa, and the Americas.

Sysmex (TSE:6869) Headlines

No Headlines